Clinical Trial Update: Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (BLOOM) evaluating MRM-3379 in male participants with Fragile X syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• MRM-3379

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Fragile X Syndrome | Phase 2 | Status: RECRUITING